UVA Zion Crossroads Dialysis in Gordonsville, Virginia - Dialysis Center

UVA Zion Crossroads Dialysis is a medicare approved dialysis facility center in Gordonsville, Virginia and it has 12 dialysis stations. It is located in Louisa county at 75 Circle Pointe Dr, Gordonsville, VA, 22942. You can reach out to the office of UVA Zion Crossroads Dialysis at (434) 924-9009. This dialysis clinic is managed and/or owned by State Owned. UVA Zion Crossroads Dialysis has the following ownership type - Non-Profit. It was first certified by medicare in June, 1997. The medicare id for this facility is 493505 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameUVA Zion Crossroads Dialysis
Location75 Circle Pointe Dr, Gordonsville, Virginia
No. of Dialysis Stations 12
Medicare ID493505
Managed ByState Owned
Ownership TypeNon-Profit
Late Shifts Yes

Contact Information


75 Circle Pointe Dr, Gordonsville, Virginia, 22942
(434) 924-9009

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with UVA Zion Crossroads Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1427164383
Organization NameUva Health Sciences Center
Doing Business AsRector & Visitors Of The University Of Virginia
Address75 Circle Pt Gordonsville, Virginia, 22942
Phone Number(434) 924-0211

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.60%67%
Patients who reported that nephrologists usually communicated and cared for them.11%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.29%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).54%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).21%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).25%14%

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.70%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.14%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.16%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).69%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).25%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).6%12%

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 86%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.14%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).75%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).21%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).4%12%

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data38
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL8

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center56
    Adult patient months included in Kt/V greater than or equal to 1.2496
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

    The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

    In Calif. and Mass., reforms proceeding even as court causes uncertainty

    News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

    Women face VA obstacles in treatment for war disorders

    Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

    Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

    Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

    Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

    New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at UVA Zion Crossroads Dialysis with elevated calcium levels.

Patients with hypercalcemia60
Hypercalcemia patient months525
Patients with Serumphosphor63
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL30
Patients with Serumphosphor from 5.6 to 7 mg/dL28
Patients with Serumphosphor greater than 7 mg/dL14

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 54
Patient months included in arterial venous fistula and catheter summaries 444
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment58
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer26

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary56
Hospitalization Rate in facility180.8 (As Expected)
Hospitalization Rate: Upper Confidence Limit321.8
Hospitalization Rate: Lower Confidence Limit105.8

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at UVA Zion Crossroads Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility16.7 (As Expected)
Readmission Rate: Upper Confidence Limit29.1
Readmission Rate: Lower Confidence Limit7.9

News Archive

Purdue Pharma supports NASCSA with $200,000 grant for state prescription drug monitoring programs

The National Association of State Controlled Substances Authorities (NASCSA) announced receipt of a $200,000 grant from Purdue Pharma L.P. today at the organization's 27th annual conference in Charleston, South Carolina. The grant is part of Purdue Pharma's ongoing efforts to support the operation, expansion and awareness of appropriately-designed state prescription drug monitoring programs, which can be an effective tool to address prescription drug abuse and diversion.

In Calif. and Mass., reforms proceeding even as court causes uncertainty

News reports offer updates on California's health exchange as well as the important signal sent by Massachusetts' major health insurers.

Women face VA obstacles in treatment for war disorders

Women are saying they face roadblocks to care when they seek treatment at Veterans Affairs hospitals, even as they return in record numbers from battlefields in Iraq and Afghanistan, ABC News reports.

Biotest, EpiVax partner to develop novel, non-immunogenic Factor VIII for hemophilia treatment

Biotest AG, Dreieich, Germany and EpiVax, Inc., Providence, Rhode Island, USA are pleased to announce a new Collaborative Research Agreement. With this collaboration a novel, non-immunogenic Factor VIII should be developed.

Study: Half of Canadians with osteoporosis have insufficient levels of vitamin D

New data presented today at the American Society for Bone and Mineral Research 2010 Annual Meeting held in Toronto, Ontario, demonstrated that approximately half of Canadians with osteoporosis have insufficient levels of vitamin D (less than 80 nmol/L), despite the fact that more than 40 per cent are prescribed at least 2800 IU of vitamin D per week.

Read more Medical News

› Verified 5 days ago